Catalyst Pharmaceuticals Inc (CPRX) Annual Balance Sheets

Annual · GAAP · USD millions
Access CPRX quarterly Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Catalyst Pharmaceuticals Inc finances operations and invests in assets.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent709.17
Short-term Investments, Total0.00
Cash & Short-term Investments709.00
Accounts receivable126.48
Inventories37.17
Other Current Assets0.00
Prepaid Expense And Other Assets Current21.22
Total Current Assets894.03
Equipment/Property/Plant Net1.04
Intangible Assets131.67
Deposits Assets, Noncurrent AS0.00
Other Assets, Noncurrent77.24
Operating Lease Right Of Use Asset1.94
Total Assets1,103.98
Liabilities
Accounts Payable, Current AC11.20
Accrued Liabilities, Current AC135.95
Total Current Liabilities147.15
Total Long-term Debt0.00
Other liabilities, Noncurrent2.56
OperatingLeaseLiabilityNoncurrent2.35
Total Liabilities149.71
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock479.96
Retained Earnings / Accumulated Deficit474.19
Other Equity0.00
Common Stockholder's Equity954.27
Total Stockholder's Equity954.27
Liabilities & Stockholder's Equity1,103.98
4 historic quarters locked

Sign in to unlock the full Catalyst Pharmaceuticals Inc balance sheet history.

About Catalyst Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 25, 2026
  • Source: cprx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-071525

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.